PLK1 and laryngeal squamous cell carcinoma: Besides, SKA3 overexpression facilitated proliferation and chemoresistance of laryngeal squamous cell carcinoma (LSCC) by reprogramming PLK1–AKT axis-mediated glycolytic metabolism, which was also related to the unfavorable prognosis of LSCC patients [25].